COMBINATION THERAPY OF KRAS INHIBITOR AND SHP2 INHIBITOR FOR TREATMENT OF CANCERS

Provided herein are methods of administering a KRAS G12C inhibitor in combination with a SHP2 inhibitor to a cancer subject. L'invention concerne des procédés d'administration d'un inhibiteur de KRAS G12C en combinaison avec un inhibiteur de SHP2 à un sujet cancéreux.

Saved in:
Bibliographic Details
Main Authors LIPFORD, James Russell, HENARY, Haby
Format Patent
LanguageEnglish
French
Published 22.04.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided herein are methods of administering a KRAS G12C inhibitor in combination with a SHP2 inhibitor to a cancer subject. L'invention concerne des procédés d'administration d'un inhibiteur de KRAS G12C en combinaison avec un inhibiteur de SHP2 à un sujet cancéreux.
Bibliography:Application Number: WO2020US55620